Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ...
SAN ANTONIO, July 07, 2026--bioAffinity Technology reports continued acceleration in commercial sales for its CyPath® Lung ...
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can ...
Among patients with a very early diagnosis of systemic sclerosis (VEDOSS), a baseline diffusing capacity of the lungs for carbon monoxide by single breath (DLCO/SB) below 70% was associated with a ...
Connective tissue diseases (CTDs) associated with interstitial lung disease (ILD) involve autoimmune disorders affecting the skin, joints, and lungs, leading to inflammation and fibrosis. Conditions ...
Removing a patient’s race from an equation used to assess lung function — a change called for by health equity advocates — would mean that the lung disease of nearly half a million Black Americans ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit ...
Getting Covid could increase your risk of developing pulmonary hypertension, a deadly blood pressure condition. In a new study published in Scientific Reports, researchers found that people who ...
Veterans Affairs department officials said Monday they have launched a study to determine how removing race from widely used lung function tests may affect disability benefits for veterans, and they ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results